CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
Conference
"HAART-Less : Current Evidence and Future Implications" Dr. Robert Hogg (biography) English - 2002-04-14 - 33 minutes
Summary : Highly active antiretroviral therapy has been shown to dramatically decrease morbidity and mortality in symptomatic and asymptomatic HIV infected individuals. As a result, these antiretroviral drug regimens have been widely adopted for the treatment of HIV infection. In the past recommendations for the initiation of antiretroviral therapy were largely based on both CD4 cell count and plasma HIV RNA levels. Current observational evidence suggests that rates of disease progression to AIDS or death among those on antiretroviral therapy are a function of baseline CD4 cell counts rather than HIV RNA levels. The aim of Dr. Hogg's talk is to briefly characterize patterns of disease progression among persons on antiretroviral therapy. The presentation will focus on characterizing patterns of antiretroviral usage, changes in rates of morbidity and mortality and salient prognostic factors associated with disease progression in this province. As well, Dr Hogg will compare current patterns of disease progression in the province of British Columbia with evidence from other observational studies from around the world. In addition, he will explore how these findings may impact on current guidelines and on antiretroviral access in regions outside North America, Europe and Oceania.
Dr. Hogg's work is supported in part by a career investigator award from the Michael Smith Foundation for Health Research and an investigator award from the Canadian Institutes of Health Research.
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
